Novo Nordisk
NVO
NVO
564 hedge funds and large institutions have $8.88B invested in Novo Nordisk in 2019 Q3 according to their latest regulatory filings, with 55 funds opening new positions, 179 increasing their positions, 211 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
0% less capital invested
Capital invested by funds: $8.89B → $8.88B (-$10.8M)
0.2% less ownership
Funds ownership: 18.73% → 18.53% (-0.2%)
15% less repeat investments, than reductions
Existing positions increased: 179 | Existing positions reduced: 211
Holders
564
Holding in Top 10
9
Calls
$79.2M
Puts
$47.1M
Top Buyers
| 1 | +$117M | |
| 2 | +$38.4M | |
| 3 | +$36.2M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$34M |
| 5 |
Capital International Investors
Los Angeles,
California
|
+$26.9M |
Top Sellers
| 1 | -$84.9M | |
| 2 | -$50.8M | |
| 3 | -$49.6M | |
| 4 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
-$37.4M |
| 5 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
-$37.4M |